Radiation- Induced Alopecia in Patients Undergoing Radiation Therapy to the Brain
NCT03543020 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2019-03-04
Summary
Study will be conducted on patients receiving Whole brain(WB) / Partial Brain(PB) radiotherapy using volumetric modulated arc therapy or intensity modulated radiotherapy at Department of Radiation Oncology, Fortis Memorial Research Insititute, Gurgaon, Haryana with end points. 1) Primary - To observe degree of alopecia at conclusion of radiotherapy compared to pre- radiotherapy status using scalp sparing radiotherapy technique. 2) Secondary 1)Recording the temporal dose levels causing radiation associated alopecia and dose range acceptable for reversible radiation-induced alopecia and determine dose volume threshold for the same 2)Recording of scalp doses by in vivo dosimetry and correlation with radiation induced alopecia Methods: Study includes 50 patients of partial / whole brain radiation therapy to be followed consecutively for radiation- induced alopecia. Contouring: For WB radiation entire scalp will be contoured. For PB irradiation contouring of partial scalp to be done by drawing 2-3 cm beyond the PTV edge in all directions. Planning: The treatment planning and delivery to be done as per existing practice in department. Contouring at Monaco / Brain Lab Contouring stations and planning on Monaco Treatment planning system (TPS) Version 5.11.01. Duration: 18 months for patient accrual; in this observational study patients undergoing radiation therapy to brain will be evaluated clinically and objectively for degree of alopecia. Photographic and Clinical record of four views of scalp- Right lateral, Left lateral, top and rear to be taken at intervals- a)Pre-Radiotherapy (RT) b) RT Conclusion c) First follow-up at 1 month. Hair loss quantified using Severity of Alopecia Tool (SALT) Score. Dosimetric measurements having subcomponents - measurement of surface dose uses optically stimulated luminescence dosimeters to be placed over scalp for first 5 fractions in case of conventional or fractionated SRT, for the entire duration of short course treatments and for first 5 fractions in case of palliative whole brain radiation given over 10 fractions. TPS measurements: Average, maximum dose and dose per unit volume will be reported for whole and partial scalp. Outcomes 1. Quantify the degree of alopecia at the conclusion of radiotherapy as compared to pre- radiotherapy status. 2. To record the radiation dose levels causing alopecia. 3. Obtain in vivo dosimetry values for scalp doses in modern radiotherapy treatment
Conditions
- Alopecia; X-Rays
Interventions
- RADIATION
-
radiation therapy to brain
OSL placed over the scalp for initial 5 fractions for patients undergoing partial/ whole brain radiation therapy
Sponsors & Collaborators
-
Fortis Memorial Research Institute
lead INDUSTRY
Principal Investigators
-
Meena Mishra, M.D. · Fortis Memorial Research Institute, Gurgaon, Haryana, India
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-17
- Primary Completion
- 2018-12-31
- Completion
- 2019-01-30
Countries
- India
Study Locations
More Related Trials
-
Radiation Therapy Following Surgery to Remove Brain Metastases
NCT00003320 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
NCT00002708 ·Status: COMPLETED ·Phase: PHASE3
-
Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases
NCT00814463 ·Status: TERMINATED ·Phase: PHASE2
-
Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases
NCT05438212 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis
NCT00280475 ·Status: COMPLETED ·Phase: PHASE3
-
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
NCT06344130 ·Status: RECRUITING ·Phase: PHASE1
-
Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases
NCT02353000 ·Status: TERMINATED ·Phase: NA
-
Sequence of Radiation and Targeted Therapy in Brain Metastases
NCT04832672 ·Status: COMPLETED
-
Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases
NCT02080949 ·Status: WITHDRAWN ·Phase: PHASE1
-
Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
NCT01464177 ·Status: COMPLETED ·Phase: PHASE2
-
Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
NCT04536649 ·Status: UNKNOWN ·Phase: PHASE3
-
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
NCT06140875 ·Status: RECRUITING ·Phase: NA
-
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
NCT03750227 ·Status: RECRUITING ·Phase: PHASE3
-
Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
NCT01372774 ·Status: COMPLETED ·Phase: PHASE3
-
Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00053183 ·Status: COMPLETED ·Phase: PHASE1
-
Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases
NCT04084431 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Randomized Trial Between WBRT Plus SRS Versus SRS Alone for 1-4 Brain Metastases
NCT00406835 ·Status: COMPLETED
-
Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
NCT02187822 ·Status: TERMINATED ·Phase: PHASE1
-
Radiation Therapy in Treating Patients With Brain Cancer
NCT00002620 ·Status: COMPLETED ·Phase: PHASE3
-
Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study
NCT04047602 ·Status: TERMINATED ·Phase: NA
-
Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors
NCT03163368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma
NCT06831773 ·Status: RECRUITING ·Phase: NA
-
Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases
NCT03414944 ·Status: UNKNOWN ·Phase: NA
-
Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
NCT00058370 ·Status: COMPLETED ·Phase: NA
-
Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence
NCT03303365 ·Status: COMPLETED ·Phase: NA